315 related articles for article (PubMed ID: 34425811)
1. Paradoxical effects of cigarette smoke and COPD on SARS-CoV-2 infection and disease.
Tomchaney M; Contoli M; Mayo J; Baraldo S; Li S; Cabel CR; Bull DA; Lick S; Malo J; Knoper S; Kim SS; Tram J; Rojas-Quintero J; Kraft M; Ledford JG; Tesfaigzi Y; Martinez FD; Thorne CA; Kheradmand F; Campos SK; Papi A; Polverino F
BMC Pulm Med; 2021 Aug; 21(1):275. PubMed ID: 34425811
[TBL] [Abstract][Full Text] [Related]
2. Paradoxical effects of cigarette smoke and COPD on SARS-CoV2 infection and disease.
Tomchaney M; Contoli M; Mayo J; Baraldo S; Shuaizhi L; Cabel CR; Bull DA; Lick S; Malo J; Knoper S; Kim SS; Tram J; Rojas-Quintero J; Kraft M; Ledford J; Tesfaigzi Y; Martinez FD; Thorne CA; Kheradmand F; Campos SK; Papi A; Polverino F
bioRxiv; 2020 Dec; ():. PubMed ID: 33330864
[TBL] [Abstract][Full Text] [Related]
3. Dysbalance of ACE2 levels - a possible cause for severe COVID-19 outcome in COPD.
Fließer E; Birnhuber A; Marsh LM; Gschwandtner E; Klepetko W; Olschewski H; Kwapiszewska G
J Pathol Clin Res; 2021 Sep; 7(5):446-458. PubMed ID: 33978304
[TBL] [Abstract][Full Text] [Related]
4. Cigarette Smoke Stimulates SARS-CoV-2 Internalization by Activating AhR and Increasing ACE2 Expression in Human Gingival Epithelial Cells.
Almeida-da-Silva CLC; Matshik Dakafay H; Liu K; Ojcius DM
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299289
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of the SARS-CoV-2 receptor ACE2 is induced by cigarette smoke in bronchial and alveolar epithelia.
Liu A; Zhang X; Li R; Zheng M; Yang S; Dai L; Wu A; Hu C; Huang Y; Xie M; Chen Q
J Pathol; 2021 Jan; 253(1):17-30. PubMed ID: 32991738
[TBL] [Abstract][Full Text] [Related]
6. Connective Tissue Growth Factor Promotes Pulmonary Epithelial Cell Senescence and Is Associated with COPD Severity.
Jang JH; Chand HS; Bruse S; Doyle-Eisele M; Royer C; McDonald J; Qualls C; Klingelhutz AJ; Lin Y; Mallampalli R; Tesfaigzi Y; Nyunoya T
COPD; 2017 Apr; 14(2):228-237. PubMed ID: 28026993
[TBL] [Abstract][Full Text] [Related]
7. Inhaled corticosteroids downregulate the SARS-CoV-2 receptor ACE2 in COPD through suppression of type I interferon.
Finney LJ; Glanville N; Farne H; Aniscenko J; Fenwick P; Kemp SV; Trujillo-Torralbo MB; Loo SL; Calderazzo MA; Wedzicha JA; Mallia P; Bartlett NW; Johnston SL; Singanayagam A
J Allergy Clin Immunol; 2021 Feb; 147(2):510-519.e5. PubMed ID: 33068560
[TBL] [Abstract][Full Text] [Related]
8. In well-differentiated primary human bronchial epithelial cells, TGF-
O'Sullivan MJ; Mitchel JA; Mwase C; McGill M; Kanki P; Park JA
Am J Physiol Lung Cell Mol Physiol; 2021 Feb; 320(2):L246-L253. PubMed ID: 33174447
[TBL] [Abstract][Full Text] [Related]
9. Elevated FiO
Myti D; Gunjak M; Casado F; Khaghani Raziabad S; Nardiello C; Vadász I; Herold S; Pryhuber G; Seeger W; Morty RE
Am J Physiol Lung Cell Mol Physiol; 2020 Oct; 319(4):L670-L674. PubMed ID: 32878480
[TBL] [Abstract][Full Text] [Related]
10. SARS-CoV-2 infection aggravates cigarette smoke-exposed cell damage in primary human airway epithelia.
Chen R; Hui KP; Liang Y; Ng KC; Nicholls JM; Ip MS; Peiris M; Chan MC; Mak JC
Virol J; 2023 Apr; 20(1):65. PubMed ID: 37041586
[TBL] [Abstract][Full Text] [Related]
11. Dysregulation of endocytic machinery and ACE2 in small airways of smokers and COPD patients can augment their susceptibility to SARS-CoV-2 (COVID-19) infections.
Eapen MS; Lu W; Hackett TL; Singhera GK; Thompson IE; McAlinden KD; Hardikar A; Weber HC; Haug G; Wark PAB; Chia C; Sohal SS
Am J Physiol Lung Cell Mol Physiol; 2021 Jan; 320(1):L158-L163. PubMed ID: 33174446
[TBL] [Abstract][Full Text] [Related]
12. Smoke and Spike: Benzo[a]pyrene Enhances SARS-CoV-2 Infection by Boosting NR4A2-Induced ACE2 and TMPRSS2 Expression.
Liu W; Zhao Y; Fan J; Shen J; Tang H; Tang W; Wu D; Huang W; Ding Y; Qiao P; Lin J; Li Z; Li Q; Cui Q; Liu Y; Chen Y; Pu R; Han X; Yin J; Tan X; Cao G
Adv Sci (Weinh); 2023 Sep; 10(26):e2300834. PubMed ID: 37428471
[TBL] [Abstract][Full Text] [Related]
13. The TMPRSS2 Inhibitor Nafamostat Reduces SARS-CoV-2 Pulmonary Infection in Mouse Models of COVID-19.
Li K; Meyerholz DK; Bartlett JA; McCray PB
mBio; 2021 Aug; 12(4):e0097021. PubMed ID: 34340553
[TBL] [Abstract][Full Text] [Related]
14. Imiquimod Boosts Interferon Response, and Decreases ACE2 and Pro-Inflammatory Response of Human Bronchial Epithelium in Asthma.
Nieto-Fontarigo JJ; Tillgren S; Cerps S; Sverrild A; Hvidtfeldt M; Ramu S; Menzel M; Sander AF; Porsbjerg C; Uller L
Front Immunol; 2021; 12():743890. PubMed ID: 34950134
[TBL] [Abstract][Full Text] [Related]
15. SARS-CoV-2 (COVID-19) Adhesion Site Protein Upregulation in Small Airways, Type 2 Pneumocytes, and Alveolar Macrophages of Smokers and COPD - Possible Implications for Interstitial Fibrosis.
Brake SJ; Eapen MS; McAlinden KD; Markos J; Haug G; Larby J; Chia C; Hardikar A; Singhera GK; Hackett TL; Lu W; Sohal SS
Int J Chron Obstruct Pulmon Dis; 2022; 17():101-115. PubMed ID: 35046647
[TBL] [Abstract][Full Text] [Related]
16. Comparative analysis of ACE2 protein expression in rodent, non-human primate, and human respiratory tract at baseline and after injury: A conundrum for COVID-19 pathogenesis.
Soni S; Jiang Y; Tesfaigzi Y; Hornick JL; Çataltepe S
PLoS One; 2021; 16(2):e0247510. PubMed ID: 33626084
[TBL] [Abstract][Full Text] [Related]
17. Dysregulation of COVID-19 related gene expression in the COPD lung.
Watson A; Öberg L; Angermann B; Spalluto CM; Hühn M; Burke H; Cellura D; Freeman A; Muthas D; Etal D; Belfield G; Karlsson F; Nordström K; Ostridge K; Staples KJ; Wilkinson T;
Respir Res; 2021 May; 22(1):164. PubMed ID: 34051791
[TBL] [Abstract][Full Text] [Related]
18. Upregulation of ACE2 and TMPRSS2 by particulate matter and idiopathic pulmonary fibrosis: a potential role in severe COVID-19.
Li HH; Liu CC; Hsu TW; Lin JH; Hsu JW; Li AF; Yeh YC; Hung SC; Hsu HS
Part Fibre Toxicol; 2021 Mar; 18(1):11. PubMed ID: 33706759
[TBL] [Abstract][Full Text] [Related]
19. Hypercapnia increases ACE2 expression and pseudo-SARS-CoV-2 entry in bronchial epithelial cells by augmenting cellular cholesterol.
Chen F; Matsuda A; Budinger GRS; Sporn PHS; Casalino-Matsuda SM
Front Immunol; 2023; 14():1251120. PubMed ID: 37901225
[TBL] [Abstract][Full Text] [Related]
20. Increased Expression of
Manevski M; Devadoss D; Long C; Singh SP; Nasser MW; Borchert GM; Nair MN; Rahman I; Sopori M; Chand HS
Front Immunol; 2022; 13():803362. PubMed ID: 35774797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
